Showing 5,281 - 5,300 results of 5,484 for search '"Pharmaceutical"', query time: 0.06s Refine Results
  1. 5281

    The use of triptans as an effective form of migraine treatment – review by Agata Borkowska, Anna Kiełb, Anna Mich, Anna Kaźmierczak, Patrycja Sornek, Wiktoria Izdebska, Igor Pawlak, Radosław Ciesielski, Jakub Stanek, Klaudia Perkowska

    Published 2025-01-01
    “…Results Studies consistently show high efficacy of triptans in treating acute migraines. These pharmaceuticals markedly alleviate pain and symptoms like nausea, photophobia, and phonophobia, providing substantial pain relief. …”
    Get full text
    Article
  2. 5282

    Risk characterisation of chemicals of emerging concern in real-life water reuse applications by Jan C. Specker, Antonia Praetorius, Milo L. de Baat, Nora B. Sutton, Annemarie P. van Wezel

    Published 2025-01-01
    “…However, a thorough risk assessment of CECs during water reuse is currently limited due to a focus on a defined class of contaminants in the literature, i.e., pharmaceuticals, and falls short of per- and polyfluoroalkyl substances. …”
    Get full text
    Article
  3. 5283

    Occurrence of Acetaminophen, Amoxicillin, Diclofenac and Methylparaben in Lagos and Ologe Lagoons, Lagos, Nigeria by O.S. Folarin, A.A. Otitoloju, N.H. Amaeze, J.K. Saliu

    Published 2020-01-01
    “…The study established that there are active pharmaceuticals compounds and excipients present in the Nigerian aquatic environment which are  micropollutants of emerging environmental concerns and of significant ecological risk. …”
    Get full text
    Article
  4. 5284

    Impact of fluoxetine exposure on Lymnaea stagnalis and its developing eggs: integrating untargeted lipidomics, targeted metabolomics, and classical risk assessment by Diana Ilyaskina, Yumi Nakadera, Yumi Nakadera, Marja H. Lamoree, Joris M. Koene, Pim E. G. Leonards

    Published 2025-02-01
    “…Pharmaceuticals such as selective serotonin reuptake inhibitors (SSRIs), are increasingly detected in aquatic environments, posing potential risks to non-target organisms, because many of those substances are widely shared neuromodulator. …”
    Get full text
    Article
  5. 5285

    Selecting drug formulation for the treatment and prevention of retinal disorders by O.V. Filippova

    Published 2019-11-01
    “…Blood-ocular barrier prevents many pharmaceuticals from entering posterior eye segment, in particular, the retina. …”
    Get full text
    Article
  6. 5286

    Protective effect of nigella sativa and thymoquinone on relative liver weight increase caused by aflatoxin in broilers by Mehmet Burak Ateş, Mustafa Ortatatlı

    Published 2020-06-01
    “…<b>Aim: </b>It is aimed to determine the preventive effect of black seed (Nigella sativa L; NS) and its pharmaceutically active substance volatile fatty acid thymoquinone on relative liver weight increase in broiler in aflatoxicosis..…”
    Get full text
    Article
  7. 5287

    Extraction of Oil from Azadirachta indica and Moringa stenopetala Seeds and Evaluation of its Physicochemical Properties by Degnechew Genene

    Published 2024-12-01
    “…., roots, stems, foliage, seeds, and barks) can be used as food additives and as raw materials for pharmaceuticals, cosmetics, soap, and biofuel processing industries. …”
    Get full text
    Article
  8. 5288

    Occurrence of Acetaminophen, Amoxicillin, Diclofenac and Methylparaben in Lagos and Ologe Lagoons, Lagos, Nigeria by O.S. Folarin, A.A. Otitoloju, N.H. Amaeze, J.K. Saliu

    Published 2020-01-01
    “…The study established that there are active pharmaceuticals compounds and excipients present in the Nigerian aquatic environment which are  micropollutants of emerging environmental concerns and of significant ecological risk. …”
    Get full text
    Article
  9. 5289

    Telaprevir in treatment of chronic hepatitis C: safety issues by T. M. Ignatova

    Published 2012-07-01
    “…Special attention is given to prophylaxis of interactions with other pharmaceuticals, as telaprevir is P450 (СYP) 3A4 substrate and inhibitor and P-glycoprotein transporter.Conclusion. …”
    Get full text
    Article
  10. 5290

    High Stability Single-Port Dual Band Microwave Sensor Based on Interdigital Capacitor Structure With Asymmetry Branch Feedline by Syah Alam, Indra Surjati, Lydia Sari, Raden Deiny Mardian, Teguh Firmansyah, Muhammad Iqbal, Slamet Widodo, Mudrik Alaydrus, Zahriladha Zakaria

    Published 2025-01-01
    “…Therefore, this sensor can be recommended for several applications such as biomedical industry, pharmaceuticals and material quality control especially for outdoor measurements that are potentially affected by electromagnetic interference and disturbance.…”
    Get full text
    Article
  11. 5291

    Microalgae-based bioremediation of refractory pollutants: an approach towards environmental sustainability by Mostafa M. El-Sheekh, Hala Y. El-Kassas, Sameh S. Ali

    Published 2025-01-01
    “…Therefore, this review discusses the mechanism and the ability of different microalgal species to mitigate persistent refractory pollutants, such as industrial effluents, dyes, pesticides, and pharmaceuticals. Also, this review paper provided insight into the production of nanomaterials, nanoparticles, and nanoparticle-based biosensors from microalgae and the immobilization of microalgae on nanomaterials to enhance bioremediation process efficiency. …”
    Get full text
    Article
  12. 5292

    Bridging Molecular Docking to Molecular Dynamics to Enlighten Recognition Processes of Tailored D-A/D-A-D Types' AIEgens with HSA/BSA by Harun Nalçakan, Gülbin Kurtay

    Published 2023-09-01
    “…In this scope, we performed a detailed molecular dock-ing study of Donor (D)-Acceptor (A) or D-A-D type luminogens with two blood proteins; namely bovine serum albumin (BSA) and human serum albumin (HSA), which appeared as robust carriers of several pharmaceuticals against preliminary cancer diseases. Our results revealed that the binding scores of the Dn-An or Dn-An-Dn:BSA complexes ranged from -8.5 to -11.7 kcal/mol while Dn-An or Dn-An-Dn:HSA complexes showed scores varying from -8.4 to -10.5 kcal/mol. …”
    Get full text
    Article
  13. 5293

    The Burden of Cost in Bronchiolitis Obliterans Syndrome: Predictions for the Next Decade by Christopher A. Jones, David G. Chapman, Peter Weimersheimer, Luca Fernandez, Oscar Alejandro Mesa, Christian Peters, Bart M. Vanaudenaerde, Mitchell C. Norotsky, Robin Vos

    Published 2016-06-01
    “…., hospitalizations, pharmaceuticals, devices), and non-medical direct costs such as monitoring and professional caregiving. …”
    Get full text
    Article
  14. 5294
  15. 5295
  16. 5296
  17. 5297
  18. 5298
  19. 5299
  20. 5300